Citi Reiterates Neutral Rating on Alnylam Pharmaceuticals (ALNY)
Go back to Citi Reiterates Neutral Rating on Alnylam Pharmaceuticals (ALNY)| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 223.34 +2.14 (0.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $221.20 | 52 Week High | $109.10 | |||
| Open | $219.00 | 52 Week Low | $31.38 | |||
| Day High | $224.50 | P/E | N/A | |||
| Day Low | $219.00 | EPS | $-1.45 | |||
| Volume | 317,564 | |||||
